Revance Therapeutics (RVNC)
(Delayed Data from NSDQ)
$3.95 USD
+0.18 (4.77%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.90 -0.05 (-1.27%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.66 | 0.00% |
Earnings Summary
For their last quarter, Revance Therapeutics (RVNC) reported earnings of -$0.62 per share, beating the Zacks Consensus Estimate of $-0.79 per share. This reflects a positive earnings surprise of 21.52%. Look out for RVNC's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.66 per share, reflecting a year-over-year increase of 10.81%.
Earnings History
Price & Consensus
Zacks News for RVNC
Qiagen (QGEN) Surpasses Q1 Earnings and Revenue Estimates
RVNC: What are Zacks experts saying now?
Zacks Private Portfolio Services